A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any ...

The CNBC host said that he has reminded his viewers repeatedly that when the Fed is your “enemy” you should stick to ...

With prices finalized for the first 10 Medicare Part D drugs selected for the initial round of pricing negotiations, ...

Dupixent is the first biologic medicine approved in the U.S. for the common lung condition, though competitors from GSK, AstraZeneca and Roche could follow.

In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent, prevalent, and ...

Earlier this month, GSK announced topline results from a Phase III trial of its injectable antibody Nucala for COPD. Specific data has not yet been shared beyond a general statement that Nucala led to ...

Actor and advocate Brooke Shields says learning how to embrace aging and prioritize preventive health in her 50s feels "like ...

In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent, prevalent, and ...

Researchers have developed MED6-189, a new drug effective against drug-sensitive and drug-resistant strains of human malaria ...

GSK PLC GSK shares inched down 0.33% to £15.22 Thursday, on what proved to be an all-around favorable trading session for the ...

England’s drug pricing regulator declined to recommend GSK Plc’s long-acting HIV prevention injection, asking the company for ...